Sterling Lab, Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Sterling Lab, Pharmaceutical Export Portfolio Dataset — 4 Products, $5.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sterling Lab, — Pharmaceutical Exporter Profile (2026) | 4 Products, $5.0M Trade | TransData Nexus

Sterling Lab,

Indian Pharmaceutical Exporter · Antibiotics Specialist · $5.0M Total Trade · DGFT Verified

Sterling Lab, is an Indian pharmaceutical exporter with a total trade value of $5.0M across 4 products in 3 therapeutic categories. Based on 101 verified export shipments from Indian Customs (DGFT) records, Sterling Lab, is the #1 Indian exporter in 1 product including Lactulose. Top exports include Cephalexin ($1.9M), Cefuroxime ($1.4M), Lactulose ($950.0K).

Sterling Lab, — Export Portfolio & Destination Treemap

Sterling Lab, pharmaceutical export portfolio — 4 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Sterling Lab,? — Company Overview & Market Position

Established in 1989, Sterling Lab is an Indian pharmaceutical company specializing in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company is headquartered in Bengaluru, Karnataka, India, with its manufacturing facility located in Hosur, Tamil Nadu. Sterling Lab operates as a privately held entity, with a workforce of approximately 100 employees. The company is registered under the Corporate Identification Number (CIN) 33AVCPS5288B1ZL. Sterling Lab's official website is www.sterlinglab.com.

Over the years, Sterling Lab has expanded its product portfolio to include a wide range of human and animal health pharmaceuticals. The company's human health segment offers antibiotics, antibacterials, antidiabetics, analgesics, anti-inflammatory drugs, and more. In the animal health segment, Sterling Lab provides products for various species, including poultry, cattle, and aquaculture, such as antibiotics, antibacterials, anthelmintics, and feed supplements.

What Does Sterling Lab, Export? — Product Portfolio Analysis

Top Products by Export Value

1Cephalexin$1.9M

Product Portfolio — Top 4 by Export Value

Sterling Lab, exports 4 pharmaceutical products across 3 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Cephalexin	Antibiotics	$1.9M	37	0.5%	6
2	Cefuroxime	Advanced Antibiotics	$1.4M	29	1.1%	9
3	Lactulose	Gastrointestinal	$950.0K	19	7.1%	1
4	Amoxicillin	Antibiotics	$800.0K	16	0.1%	13

Sterling Lab, exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $5.0M. The company is the #1 Indian exporter in 1 product: Lactulose. The top category is Antibiotics (52.5% of portfolio), followed by Advanced Antibiotics (28.7%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Sterling Lab, — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Sterling Lab's state-of-the-art manufacturing facility is situated in Hosur, Tamil Nadu, India, covering a built-up area of 100,000 square feet. The plant is equipped with sophisticated HVAC and RO water systems, ensuring a controlled and hygienic environment for pharmaceutical production. Dedicated areas are designated for the manufacture of beta-lactam and non-beta-lactam products, adhering to stringent international Good Manufacturing Practice (GMP) norms, including WHO-GMP and ISO certifications.

3Key Leadership

Sterling Lab's leadership team comprises experienced professionals committed to the company's mission of delivering high-quality pharmaceutical products. The Managing Director (MD) is Mr. Ajay Dixit, who oversees the company's strategic direction and operations. The Chief Financial Officer (CFO) is Mr. Raghu A., responsible for managing the company's financial activities. The administrative office is located at 104/105, Midford House, Midford Garden, M.G. Road, Bengaluru-560 001, India.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Sterling Lab, Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Sterling Lab has made significant strides in obtaining regulatory approvals for its products in various international markets. The company holds WHO-GMP and ISO certifications, demonstrating compliance with international manufacturing standards. While specific details regarding approvals from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), and Therapeutic Goods Administration (TGA) are not publicly disclosed, the company's adherence to WHO-GMP and ISO standards suggests a commitment to meeting global regulatory requirements.

2Emerging Markets

Sterling Lab has expanded its presence in emerging markets, including Africa, Latin America, and Southeast Asia. The company's adherence to WHO-GMP and ISO standards facilitates access to these regions, as these certifications are often prerequisites for market entry. By meeting international manufacturing standards, Sterling Lab enhances its competitiveness and reliability in these emerging markets.

3Geographic Strategy

Sterling Lab's geographic strategy focuses on diversification to mitigate concentration risk. The company's export portfolio spans multiple therapeutic categories, including antibiotics, advanced antibiotics, and gastrointestinal products, with the top five products accounting for 100% of the export value. This diversification strategy enables Sterling Lab to cater to a broad range of market needs and reduces dependency on a single product or market segment.

Sterling Lab, — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Sterling Lab's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's adherence to WHO-GMP and ISO standards indicates a commitment to maintaining high manufacturing quality, which is essential for FDA approvals. Sterling Lab's focus on quality assurance and compliance with international standards positions it favorably for potential FDA approvals.

2WHO & EU GMP

Sterling Lab holds WHO-GMP and ISO certifications, reflecting its compliance with international manufacturing standards. These certifications are crucial for market access in regions that require adherence to Good Manufacturing Practice (GMP) guidelines, such as the European Union. While specific details regarding EU GMP certificates and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly disclosed, the company's WHO-GMP certification suggests a commitment to maintaining high manufacturing quality.

3CDSCO & Indian Regulatory

Sterling Lab, — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Sterling Lab operates in a competitive pharmaceutical market, with several companies offering similar products in overlapping therapeutic categories. While specific market share data is not publicly available, Sterling Lab's focus on quality assurance, adherence to international manufacturing standards, and diversified product portfolio enhance its competitiveness. The company's commitment to meeting global regulatory requirements and maintaining high manufacturing quality positions it favorably against competitors in the pharmaceutical industry.

2Key Differentiators

Sterling Lab's key differentiators include its adherence to WHO-GMP and ISO certifications, reflecting compliance with international manufacturing standards. The company's diversified product portfolio across multiple therapeutic categories, with the top five products accounting for 100% of the export value, enables it to cater to a broad range of market needs. Sterling Lab's commitment to quality assurance and proactive approach to regulatory compliance further distinguish it in the pharmaceutical industry.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Sterling Lab, as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Sterling Lab has demonstrated a consistent track record in manufacturing and exporting pharmaceutical products, with a total export value of $5.0 million USD and 101 shipments across four products in three therapeutic categories. The company's adherence to WHO-GMP and ISO standards, along with its commitment to quality assurance, indicates reliability in its manufacturing processes. Sterling Lab's diversified product portfolio and focus on meeting international regulatory requirements further enhance its reputation as a dependable supplier in the pharmaceutical industry.

2Certifications to Verify

Importers should verify the following certifications to ensure compliance with international manufacturing standards:

WHO-GMP Certification: Indicates compliance with World Health Organization Good Manufacturing Practice standards. Verification can be done through the WHO website or by contacting the company directly.

ISO Certification: Demonstrates adherence to international quality management standards. Verification can be conducted through the International Organization for Standardization (ISO) website or by contacting the company.

Frequently Asked Questions — Sterling Lab,

How many pharmaceutical products does Sterling Lab, export from India?

Sterling Lab, exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Cephalexin ($1.9M), Cefuroxime ($1.4M), Lactulose ($950.0K), Amoxicillin ($800.0K). Total export value is $5.0M.

What is Sterling Lab,'s total pharmaceutical export value?

Sterling Lab,'s total pharmaceutical export value is $5.0M, based on 101 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Sterling Lab, the #1 Indian exporter?

Sterling Lab, is the #1 Indian exporter in 1 products: Lactulose (7.1% market share).

What therapeutic categories does Sterling Lab, cover?

Sterling Lab, exports across 3 therapeutic categories. The largest are Antibiotics (52.5%, 2 products), Advanced Antibiotics (28.7%, 1 products), Gastrointestinal (18.8%, 1 products).

Get Full Sterling Lab, Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.